Methyl 2-(4-oxo-2-thioxothiazolidin-3-yl)acetate is an intermediate of Epalrestat (E565300). Epalrestat is an aldose reductase inhibitor used in the treatment of diabetic neuropathy.
参考文献
Terashima, H., et al.: J. Pharmacol. Exp. Ther., 229, 226 (1983), Kikkawa, R., et al.: Diabetologia, 24, 290 (1983), Kojima, K., et al.: Jpn. J. Ophthalmol., 29, 99 (1985),
沪ICP备17019645号
400-821-0725
